SB 73 — SCH CD-ADMIN OPIOID ANTIDOTE

*LRB09903814NHT23827b* SB0073 99THEngrossed GENERALLRB099 ASSEMBLY03814 StateNHT of23827 Illinoisb andAN 2016ACT SB0073concerning Introducededucation. 1/28/2015, by Sen.

Michael Connelly SYNOPSIS AS INTRODUCED:

ILCS 5/22-30 Amends the School Code.

Allows a school district, public school, or nonpublic school to authorize a school nurse or trained personnel to administer an undesignated dose of an opioid antidote to any person that the school nurse or trained personnel in good faith believes is having an opioid overdose.

Sets forth provisions concerning immunity;

the administration, supply, and prescription of undesignated doses of an opioid antidote;

a training curriculum to recognize and respond to an opioid overdose;

reporting to the State Board of Education;

and reporting to the General Assembly.

LRB099 03814 NHT 23827 b FISCAL NOTE ACT MAY APPLY A BILL FOR SB0073 LRB099 03814 NHT 23827 b AN ACT concerning education.

"Asthma medication" means a medicine, prescribed by (i) a physician licensed to practice medicine in all its branches, (ii) a physician assistant who has been delegated the authority to prescribe asthma medications by his or her supervising physician, or (iii) an advanced practice nurse who has a written collaborative agreement with a collaborating physician that delegates the authority to prescribe asthma medications, SB0073 Engrossed - 2 - LRB099 03814 NHT 23827 b for a pupil that pertains to the pupil's asthma and that has an individual prescription label.

Food and Drug Administration, prescribed in the name of a school district, SB0073 Engrossed - 3 - LRB099 03814 NHT 23827 b public school, or nonpublic school.

SB0073 Engrossed - 4 - LRB099 03814 NHT 23827 b (A) the name and purpose of the epinephrine auto-injector;

(i) provide an undesignated epinephrine auto-injector to a student for self-administration only or any personnel authorized under a student's Individual Health Care Action Plan, Illinois Food Allergy Emergency Action Plan and Treatment Authorization Form, or plan pursuant to Section 504 of the federal Rehabilitation Act of 1973 to administer to the SB0073 Engrossed - 5 - LRB099 03814 NHT 23827 b student, that meets the student's prescription on file;

(c) The school district, public school, or nonpublic school must inform the parents or guardians of the pupil, in writing, that the school district, public school, or nonpublic school and its employees and agents, including a physician, physician assistant, or advanced practice nurse providing standing protocol or a prescription for school epinephrine auto-injectors and including a health care professional providing a prescription for or dispensation of doses of an opioid antidote, are to incur no liability or professional discipline, except for willful and wanton conduct, as a result of any injury arising from the administration of asthma medication, or of an epinephrine auto-injector, or a dose of an opioid antidote regardless of whether authorization was given SB0073 Engrossed - 6 - LRB099 03814 NHT 23827 b by the pupil's parents or guardians or by the pupil's physician, physician assistant, or advanced practice nurse, or health care professional.

(c-5) When Upon the effective date of this amendatory Act of the 98th General Assembly, when a school nurse or trained personnel administers an undesignated epinephrine auto-injector to a person whom the school nurse or trained personnel in good faith believes is having an anaphylactic SB0073 Engrossed - 7 - LRB099 03814 NHT 23827 b reaction or administers a dose of an opioid antidote to a person whom the school nurse or trained personnel in good faith believes is having an opioid overdose, notwithstanding the lack of notice to the parents or guardians of the pupil or the absence of the parents or guardians signed statement acknowledging no liability, except for willful and wanton conduct, the school district, public school, or nonpublic school and its employees and agents, and a physician, a physician assistant, or an advanced practice nurse providing standing protocol or a prescription for undesignated epinephrine auto-injectors or a health care professional providing a prescription for or dispensation of undesignated doses of an opioid antidote, are to incur no liability or professional discipline, except for willful and wanton conduct, as a result of any injury arising from the use of an undesignated epinephrine auto-injector or the use of an undesignated dose of an opioid antidote regardless of whether authorization was given by the pupil's parents or guardians or by the pupil's physician, physician assistant, or advanced practice nurse, or health care professional.

SB0073 Engrossed - 8 - LRB099 03814 NHT 23827 b (e) Provided that the requirements of this Section are fulfilled, a pupil with asthma may self-administer and self-carry his or her asthma medication or a pupil may self-administer and self-carry an epinephrine auto-injector (i) while in school, (ii) while at a school-sponsored activity, (iii) while under the supervision of school personnel, or (iv) before or after normal school activities, such as while in before-school or after-school care on school-operated property.

(e-10) Provided that the requirements of this Section are fulfilled, a school nurse or trained personnel may administer an undesignated dose of an opioid antidote to any person whom the school nurse or trained personnel in good faith believes to be having an opioid overdose (i) while in school, (ii) while at SB0073 Engrossed - 9 - LRB099 03814 NHT 23827 b a school-sponsored activity, (iii) while under the supervision of school personnel, or (iv) before or after normal school activities, such as while in before-school or after-school care on school-operated property.

The school district, public school, or nonpublic school may maintain a supply of undesignated doses of an opioid antidote in any secure location where an individual may have an opioid SB0073 Engrossed - 10 - LRB099 03814 NHT 23827 b overdose.

Within 24 hours after the administration of an undesignated dose of an opioid antidote, a school district, public school, or nonpublic school must notify the health care professional who provided the prescription for or dispensation of the supply SB0073 Engrossed - 11 - LRB099 03814 NHT 23827 b of undesignated doses of an opioid antidote of the opioid antidote's use.

(h) A training curriculum to recognize and respond to anaphylaxis, including the administration of an undesignated SB0073 Engrossed - 12 - LRB099 03814 NHT 23827 b epinephrine auto-injector, may be conducted online or in person.

The State SB0073 Engrossed - 13 - LRB099 03814 NHT 23827 b Board is not required to create new resource materials.

(i) Within 3 days after the administration of an undesignated epinephrine auto-injector by a school nurse, trained personnel, or a student at a school or school-sponsored SB0073 Engrossed - 14 - LRB099 03814 NHT 23827 b activity, the school must report to the State Board of Education in a form and manner prescribed by the State Board the following information:

(j) By October 1, 2015 and every year thereafter, the State Board of Education shall submit a report to the General Assembly identifying the frequency and circumstances of SB0073 Engrossed - 15 - LRB099 03814 NHT 23827 b epinephrine administration during the preceding academic year.